Featured News

12/18/2024

Univest Securities, LLC Announces Closing of $2 Million Registered Direct Offering for its Client Algorhythm Holdings, I

New York, Dec. 18, 2024 (GLOBE NEWSWIRE) — Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in[...]

12/13/2024

Univest Securities, LLC Announces Closing of $2.7 Million Registered Direct Offering for its Client Lichen China Limited

New York, Dec. 13, 2024 (GLOBE NEWSWIRE) — Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in[...]

12/10/2024

Univest Securities, LLC Announces Closing of $15 Million Registered Direct Offering for its Client Universe Pharmaceutic

New York, Dec. 10, 2024 (GLOBE NEWSWIRE) — Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in[...]

08/30/2022

Univest Securities, LLC Announces Closing of $25 Million Initial Public Offering of American Depository Shares for its C

Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of an init[...]

Recommended

1.
12/18/2024

Univest Securities, LLC Announces Closing of $2 Million Registered Direct Offering for its Client Algorhythm Holdings, Inc. (NASDAQ: RIME)

2.
12/13/2024

Univest Securities, LLC Announces Closing of $2.7 Million Registered Direct Offering for its Client Lichen China Limited (NASDAQ: LICN)

3.
12/10/2024

Univest Securities, LLC Announces Closing of $15 Million Registered Direct Offering for its Client Universe Pharmaceuticals INC (NASDAQ: UPC)

4.
12/06/2024

Univest Securities, LLC Announces Closing of $9.5 Million Public Offering for its Client Algorhythm Holdings, Inc. (NASDAQ: RIME)

5.
11/25/2024

Univest Securities, LLC Announces Successful Closing of $5.1 Million Private Placement for Qualigen Therapeutics, Inc. (NASDAQ: QLGN)

6.
11/19/2024

Qualigen Therapeutics Announces $4.5 Million Private Placement of Convertible Preferred Shares

7.
11/11/2024

Houston American Energy Corp. Announces Closing of Private Placement and New Leadership to Boost Growth & Transformation.

8.
09/24/2024

Univest Securities, LLC Announces Closing of $8.0 Million Registered Follow-on Offering for its Client Elevai Labs Inc. (NASDAQ: ELAB)

01/13/2021

Chinese IPO Qilian Doubles in U.S. Trading Debut

Two Chinese initial public offerings opened for trading Tuesday, with Qilian International Holding Group making a powe...

02/24/2020

AnPac Bio-Medical Science Co., Ltd’s $16 Million Initial Public Offering

Cleary Gottlieb Steen & Hamilton LLP acted as counsel to the Company, and Sheppard Mullin Richter & Hampton LLP ...

11/15/2019

Chinese cancer diagnostics provider AnPac Bio-Medical Science sets terms for $22 million US IPO

AnPac Bio-Medical Science, a Chinese provider of multi-cancer screening tests, announced terms for its US IPO on Friday....

UNIVEST SECURITIES IN THE NEWS

01/15/2019

INmune Bio, Inc. Announces Pricing of Initial Public Offering

LA JOLLA, CA, Jan. 15, 2019 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (“INmune” or the “Company”), an immunotherapy company focused on developing therapies that harness the patient’s innate immune system to fight disease, today announced the pricing of its initial public offering (“IPO”) at a price to the public of $8.00 per share, for gross proceeds of a minimum of US$8 million and up to US$20 million.